ABVC BioPharma Inc (ABVC)

ABVC BioPharma (NASDAQ:ABVC) Issues Earnings Results - Defense World

Defense World

Biotech Innovations Drive Hope in Global Fight Against Pancreatic Cancer - Baystreet.ca

Baystreet.ca

ABVC BioPharma, Inc. (NASDAQ:ABVC) Short Interest Update - Defense World

Defense World

Get in on ABVC BioPharma Inc's (ABVC) buy-in window today! – Sete News - SETE News

SETE News

Attention Deficit Hyperactivity Disorder Market and Epidemiology 2032: Treatment Market, Therapies, Companies, FDA ... - Barchart

Barchart

Why Tesla Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - ABVC BioPharma (NA - Benzinga

Benzinga

ABVC BioPharma's AiBtl BioPharma acquires TT Life Company - TipRanks.com - TipRanks

TipRanks

AiBtl BioPharma Inc. Acquired TT Life Company, Valued at $8.33M, With 1.66M AiBtl Shares at $5 per Share

GlobeNewswire Inc.

AiBtl BioPharma Inc. Acquired TT Life Company, Valued at $8.33 M, With 1.66 M AiBtl Shares at $5 per Share - GlobeNewswire

GlobeNewswire

ABVC BioPharma Executes a Global Licensing Definitive Agreement for the Treatment of NSCLC, Expecting Aggregate ... - GlobeNewswire

GlobeNewswire

ABVC BioPharma inks $105M Oncology/Hematology deal - Investing.com ZA - Investing.com South Africa

Investing.com South Africa

ABVC BioPharma Entered into a Global Licensing Deal of Vitargus with Licensing Income of $33.5M and Royalties up to $60M

GlobeNewswire Inc.

ABVC BioPharma Entered into a Global Licensing Deal of Vitargus with Licensing Income of $33.5M and Royalties up ... - GlobeNewswire

GlobeNewswire

AiBtl BioPharma Inc. Completes $7.6M Land Deal: Exchanging Stock for Real Estate, Demonstrating the Value of ... - Yahoo Finance

Yahoo Finance

ABVC BioPharma, Inc. CEO Selected as 2024 Top 10 CEO in CEO Insights Asia Magazine - GlobeNewswire

GlobeNewswire

ABVC BioPharma Reports Annual 2023 Financials and Provides Fiscal Year 2024 First Quarter Business Update

GlobeNewswire Inc.

ABVC Stock Quote Price and Forecast - CNN

CNN

ABVC BioPharma Executes a Definitive Agreement to Receive License Fees of $3M and Royalties of 2% on Future ... - Yahoo Finance

Yahoo Finance

ABVC BioPharma Receives Australian Patent, Valid Until 2040, for Its Treatment of Major Depressive Disorder (MDD) - Yahoo Finance

Yahoo Finance

ABVC Acquires $2.96 Million Worth of Land in Asia with Stocks Priced at $3.50 per Share

GlobeNewswire Inc.

ABVC Acquires $2.96 Million Worth of Land in Asia with Stocks Priced at $3.50 per Share - GlobeNewswire

GlobeNewswire

Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Benzinga

Why Resources Connection Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket

Benzinga

Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday’s Mid- - Benzinga

Benzinga

Why SoFi Technologies Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Benzinga

ABVC BioPharma and its Subsidiary Receive $460M From AiBtl BioPharma as the First Milestone Payment of Global Licensing Fees

GlobeNewswire Inc.

Why SoFi Technologies Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday’s - Benzinga

Benzinga

ABVC BioPharma Announces Completion of Subject Treatment for Interim Analysis on ADHD Phase IIb Clinical Study

GlobeNewswire Inc.

Why American Eagle Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Benzinga

US Stocks Down; Chicago Fed National Activity Index Falls In October

Benzinga

ABVC BioPharma Receives U.S. Patent for ADHD Treatment, a $32 Billion Market

GlobeNewswire Inc.

Why American Eagle Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Tuesday’s Mid- - Benzinga

Benzinga

AiBtl signs $667m licensing deal for ABVC’s CNS drug - Pharmaceutical Technology

Pharmaceutical Technology

ABVC BioPharma Enters Definitive Agreement with Licensing Income Worth $467M and Royalties Up to $200M - Yahoo Finance

Yahoo Finance

ABVC BioPharma Reports Third Quarter 2023 Financial and Operational Results - GlobeNewswire

GlobeNewswire

Best Penny Stocks To Buy Now? 3 Biotech Stocks To Watch - Penny Stocks

Penny Stocks

ABVC BioPharma Announces Reverse Stock Split - Yahoo Finance

Yahoo Finance

ABVC BioPharma, Inc. Announces New CEO as It Targets Further Growth - Yahoo Finance

Yahoo Finance

ABVC BioPharma Provides Vitargus Update on Phase II Site Initiation Visit Conducted at Ramathibodi Hospital in ... - GlobeNewswire

GlobeNewswire

ABVC BioPharma Provides Vitargus® Update on Phase II Site Initiation Visit Conducted at Srinagarind Hospital in ... - PR Newswire

PR Newswire

ABVC BioPharma Receives $3.175 Million Investment From The Lind Partners to Continue Clinical Trials - GlobeNewswire

GlobeNewswire

ABVC Biopharma on the path to validating traditional medicine for the modern world - BioWorld Online

BioWorld Online

ABVC BioPharma ABV-1505 ADHD Phase IIa Results Presented at 2023 APSARD Conference - GlobeNewswire

GlobeNewswire

FDA Approves IND Submission Allowing ABVC BioPharma to Proceed With Clinical Study of ABV-1519 for Treatment ... - GlobeNewswire

GlobeNewswire

ABVC Provides Oncology Pipeline Updates - GlobeNewswire

GlobeNewswire

ABVC BioPharma Expands Co-Development Partnership With Rgene Corporation - GlobeNewswire

GlobeNewswire

ABVC BioPharma Inc. (NASDAQ: ABVC) Receives Approval From Taiwan Central Institution Review Board For ABV ... - BP Journal

BP Journal

ABVC Biopharma cools off following meme buzz; shares fall 33% - Seeking Alpha

Seeking Alpha

ABVC BioPharma (ABVC) Stock Price, News & Analysis - MarketBeat

MarketBeat

ABVC Stock Price and Chart — NASDAQ:ABVC — TradingView - TradingView

TradingView